Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Bullboard (TSX:VRX)

View:
Post by MNK3240on Aug 10, 2017 3:27pm

Re: Paulson and Company PR and market mechanism

This is kind of funny! These big firms (and their PRs) don't really need to say anything, their actions speak volume. It's not just anybody, when they inc/dec the portfolio size, market gets ...more  
Post by FerrariPalmbeacon Aug 10, 2017 10:03am

Paulson and Company PR

https://ih.advfn.com/p.php?pid=nmona&article=75419863
Post by FerrariPalmbeacon Aug 10, 2017 9:59am

Paulson & Co., Inc. Reiterates Confidence In Valeant

Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy
Post by FerrariPalmbeacon Aug 10, 2017 9:11am

VRX VIEW,

VRX VIEW, https://topactu.net/2017/08/valeant-pharmaceuticals-international-inc-vrx-has-a-market/
Post by Abruzzoon Aug 09, 2017 9:28pm

BRIEF-Valeant says subsidiaries in Australia are under audit

Aug 9 (Reuters) - Valeant - * Says subsidiaries in australia are under audit by the australian tax office for various years beginning in 2010 * Says the australian tax office issued a notice of ...more  
Comment by domcolumbaon Aug 09, 2017 4:11pm

RE:VRX - I'm away

Hey Ichimek I get my itchimoku signal when my hemorrhoids start to flare up. Today I got that itchy feeling so I bought more VRX at the end of the day. Dom PS does Valeant have anything ...more  
Post by Ichimekon Aug 09, 2017 3:54pm

VRX - I'm away

We might have itchimoku signal (info), but it was neglected. Now I'd stay away. I already made some nice cash from VRX.
Post by RobPhilon Aug 09, 2017 10:58am

Valeant cuts revenue forecast - 2Q 2017 Earnings

Revenue during the quarter fell 8 percent to $2.23-billion in the second quarter ended June 30. This was due to declines in volume and pricing of its generic and neurology products. Net loss narrowed ...more  
Post by MNK3240on Aug 09, 2017 9:52am

Re: Analysts target price and market behaviour

It's kind of interesting to watch that recently the analysts increase the target price for stocks and the price go down so much that they have to hide. CP rail target price increased to $229 based ...more  
Comment by mtgfree1on Aug 08, 2017 3:34pm

RE:VRX up 10% Pre-Market

Nothing has changed just shorts are doing the work. hoinb back to 22 tomorrow or day after 
Comment by mtgfree1on Aug 08, 2017 3:33pm

RE:RE:RE:RBC raised price on Valeant pharmaceutical to $21

We have seen that last week and is going to be this week . i can see $22 by the end of the week 
Post by MNK3240on Aug 08, 2017 10:41am

Reasonably good earnings, stock price up

At last based on earnings and guidance, the stock price has reacted at least for a session, that's good. The way CP rail and CNR went down on very good earnings (particularly CP rail), it seemed ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities